Experimental Evaluation of Histamine Receptor Modulation in Rat Implantation Models: Implications for Embryo Implantation and Endometrial Receptivity

Abstract

Embryo implantation is a highly coordinated physiological process requiring synchronized interactions among the developing blastocyst, maternal endometrium, endocrine signaling, immune modulation, angiogenesis, and extracellular matrix remodeling. Histamine, an endogenous biogenic amine synthesized by histidine decarboxylase (HDC), has emerged as an important regulator of reproductive physiology through activation of four G-protein-coupled receptors (H1R, H2R, H3R, and H4R). Although histamine is well recognized for its roles in allergic inflammation and neurotransmission, increasing experimental evidence indicates that it also regulates uterine receptivity, decidualization, trophoblast invasion, vascular permeability, cytokine production, and implantation-associated molecular signaling. Recent experimental work suggests that histamine promotes decidualization through epithelial amphiregulin (AREG) release and interacts with progesterone-dependent pathways during implantation.

The present experimental study evaluated the effects of pharmacological modulation of histamine receptors on embryo implantation using a rat implantation model. Forty adult female Wistar rats were allocated into five experimental groups (n = 8/group): control, histamine-treated, H1 receptor antagonist-treated, H2 receptor antagonist-treated, and combined H1/H2 receptor antagonist-treated groups. Histamine receptor modulation was performed during the peri-implantation period (gestational days 4–6). Implantation sites, pregnancy outcomes, serum estradiol and progesterone concentrations, vascular endothelial growth factor (VEGF), leukemia inhibitory factor (LIF), integrin αVβ3, homeobox A10 (HOXA10), inflammatory cytokines (TNF-α, IL-6, IL-10), oxidative stress biomarkers, histopathological alterations, immunohistochemical localization, and quantitative gene expression using RT-qPCR were evaluated.

Histamine administration significantly enhanced implantation rates, increased decidual thickness, improved uterine vascularization, elevated VEGF and LIF expression, and upregulated HOXA10 and integrin αVβ3 compared with controls (p < 0.05). Conversely, blockade of H1 and H2 receptors markedly reduced implantation success, impaired decidualization, suppressed angiogenic signaling, increased oxidative stress, and promoted inflammatory cytokine production. Histological examination demonstrated reduced stromal differentiation, diminished glandular activity, and defective vascular remodeling in antagonist-treated animals. Molecular analysis confirmed significant downregulation of implantation-associated genes and increased expression of pro-inflammatory mediators.

These findings demonstrate that histamine receptor signaling plays a fundamental role in establishing uterine receptivity and successful embryo implantation. Pharmacological modulation of histamine receptors significantly influences maternal reproductive physiology through regulation of endocrine, angiogenic, inflammatory, and molecular pathways. The study provides mechanistic insights that may contribute to developing novel therapeutic approaches for recurrent implantation failure and infertility associated with impaired endometrial receptivity.